Generic placeholder image

Current Molecular Medicine


ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Novel Treatment for Neuronopathic Lysosomal Storage Diseases-Cell Therapy / Gene Therapy

Author(s): Yoshikatsu Eto and Toya Ohashi

Volume 2, Issue 1, 2002

Page: [83 - 89] Pages: 7

DOI: 10.2174/1566524023363112

Price: $65


Most lysosomal storage diseases (LSD) exhibit neurological symptoms and there has been limited success in their treatment. Innovative treatments employing novel therapy or gene therapy may offer the prospect of improvement. Recent attempts to treat the neurological forms of LSD include neural stem cell therapy, mesenchymal stem cell therapy, hematopoietic stem cell therapy and gene therapy. Additional approaches have included substrate deprivation / chaperone therapy for the treatment of LSD. This article reviews these new technologies, discusses recent progress, and suggests their possible application.

Keywords: Neuronopathic Lysosomal, Bone marrow transplantation bmt, Enzyme replacement therapy ert, Neural stem cell nsc, adeno-associated virus

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy